Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast: Significance for breast-conserving therapy

American Journal of Clinical Pathology

Volumn 110, Issue 3, 1998, Pages 357-367

  Goldstein, Neal S ^a   Lacerna, Mario ^a   Vicini, Frank ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Atypical ductal hyperplasia; Breast; Breast conserving therapy; Cancerization of lobules; Ductal carcinoma in situ; Irradiation; Local excision; Margins

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST SURGERY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031722535     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.3.357     Document Type: Article

References (69)

1. Solin LJ, Recht A, Fourquet A, et al. Ten-year results of breast conserving surgery and definitive irradiation for intraductal carcinoma (duct carcinoma in situ) of the breast. Cancer. 1991;68:2337-2344.
2. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532-2542.
3. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer. 1995;75:1310-1319.
4. Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer. 1990;66:102-108.
5. Boyages J, Recht A, Connolly J, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol. 1990;19:29-41.
6. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg. 1994;18:63-69.
7. Fisher ER, Leeming R, Anderson S, et al. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol. 1991;47:139-147.
8. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581-1586.
9. Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 1995;31A:1425-1427.
10. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 1996;14:754-763.
11. Bornstein BA, Recht A, Connolly J, et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer. 1991;67:7-13.
12. Ray GR, Adelson J, Hayhurst E, et al. Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys. 1993;28:105-111.
13. Fisher ER. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin. 1996;47:52-64.
14. Recht A, Danoff BS, Solin LJ, et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol. 1985;3:1339-1343.
15. Zafrani B, Fourquet A, Vilcoq JR, et al. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer. 1986;57: 1299-1301.
16. Silverstein MJ, Cohlan BF, Gierson ED, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer. 1992;28:630-634.
17. Solin LJ, Fowble BL, Schultz DJ, et al. Definitive irradiation for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1990;19:843-850.
18. Haffty B, Peschel RE, Papadopoulos D, et al. Radiation therapy for ductal carcinoma in situ of the breast. Conn Med. 1990;54:482-484.
19. Fowble BL, Solin LJ, Goodman RL. Results of conservative surgery and radiation for intraductal noninvasive breast cancer. Am J Clin Oncol. 1987;10:110-111.
20. Stotter AT, McNeese M, Oswald MJ, et al. The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Radiat Oncol Biol Phys. 1990;18:283-287.
21. McCormick B, Rosen PP, Kinne D, et al. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1991;21:289-292.
22. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6), I: intraductal carcinoma (DCIS). Cancer. 1986;57:197-207.
23. Sneige N, McNeese MD, Atkinson EN, et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol. 1995;26: 642-649.
24. Kurtz J, Jacquemier J, Torhorst J, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 1989;63:1630-1635.
25. Cutuli B, Teissier E, Piat J-M, et al. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur J Cancer. 1992;28:649-654.
26. Silverstein MJ, Waisman JR, Gierson ED, et al. Radiation therapy for intraductal carcinoma: is it an equal alternative? Arch Surg. 1991;126:424-428.
27. Fisher ER, Siderits R. Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Breast Cancer Res Treat. 1992;21:165-172.
28. Recht A, Connolly J, Schnitt SJ, et al. Therapy of in situ cancer. Hematol Oncol Clin North Am. 1989;3:691-708.
29. Silverstein MJ, Gierson ED, Colburn WJ, et al. Can intraductal breast carcinoma be excised completely by local excision? clinical and pathologic predictors. Cancer. 1994;73:2985-2989.
30. van Dongen J, Holland R, Peterse H, et al. Ductal carcinoma in situ of the breast: second EORTC consensus meeting. Eur J Cancer. 1991;28:626-629.
31. Fechner RE. Ductal carcinoma involving the lobule of the breast, a source of confusion with lobular carcinoma in situ. Cancer. 1971;28:274-281.
32. Lennington WJ, Jensen RA, Dalton LW, et al. Ductal carcinoma in situ of the breast: heterogeneity of individual lesions. Cancer. 1994;73:118-124.
33. Beahrs OH, Henson D, Hutter RVP, Kennedy BJ (American Joint Committee on Cancer), eds. Breast. In: Manual for Staging of Cancer. Philadelphia, Pa: Lippincott; 1992:149-154.
34. Vicini FA, Lacerna MD, Goldstein NS, et al. Ductal carcinoma-in-situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment related factors affecting outcome with breast conserving therapy. Int J Radiat Oncol Biol Phys. 1997;39:627-635.
35. Recht A, Silver B, Schnitt SJ, et al. Breast relapse following primary radiation therapy for early breast cancer, I: classification, frequency, and salvage. Int J Radiat Oncol Biol Phys. 1985;11:1271-1276.
36. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-459.
37. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol. 1992;23:1095-1097.
38. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone; 1987.
39. Page DL, Dupont WD. Anatomic markers of human premalignancy and risk of breast cancer. Cancer. 1990;66: 1326-1335.
40. Goldstein NS, Murphy TM. Intraductal carcinoma associated with invasive carcinoma of the breast: a comparison of the two lesions with implications for intraductal carcinoma classification systems. Am J Clin Pathol. 1996;106:312-318.
41. Azzopardi JG. Underdiagnosis of malignancy. In: Bennington JL, ed. Problems in Breast Pathology. London, England: Saunders; 1979:192-239.
42. Elston CW, Ellis IO. Pathologic prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology. 1991;19:403-410.
43. Lagios MD, Margilin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade in local recurrence. Cancer. 1989;63: 618-624.
44. Lagios MD, Westdahl PR, Margolin FR, et al. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982;50:1309-1314.
45. Page DL, Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial: unanswered question remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer. 1995;75:1219-1222.
46. McKinney CD, Frierson HF, Fechner RE, et al. Pathologic findings in nonpalpable invasive breast cancer. Am J Surg Pathol. 1992;16:33-36.
47. Holland R, Connolly J, Gelman R, et al. The presence of an extensive intraductal component (EIC) following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990;8:113-118.
48. Fechner RE. One century of mammary carcinoma in situ: what have we learned? Am J Clin Pathol. 1993;100:654-661.
49. Lagios MD. Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment. Breast J. 1995;1:68-78.
50. Wood WC. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast. Semin Oncol. 1996;23:446-452.
51. Lagios MD. Duct carcinoma in situ: biological implications for clinical practice. Semin Oncol. 1996;23(suppl 1):6-11.
52. Silverstein MJ. Ductal carcinoma in situ of the breast. Br J Surg. 1997;84:145-146.
53. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267-2274.
54. Faverly D, Burgers L, Bult P, et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994;11:193-198.
55. Holland R, Hendriks JH, Verbeek AL, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 1990;335:519-522.
56. Fisher ER. Lumpectomy margins and much more. Cancer. 1997;79:1453-1458.
57. Carter D. Margins of "lumpectomy" for breast cancer. Hum Pathol. 1986;17:330-332.
58. Page DL, Dupont WD, Rogers LW, et al. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751-758.
59. Kerner H, Lichtig C. Lobular cancerization: incidence and differential diagnosis with lobular carcinoma in situ of breast. Histopathology. 1986;10:621-629.
60. Welling SR, Jensen HM. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst. 1973;50:1111-1118.
61. Fourquet A, Campana F, Zifrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25 year follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719-725.
62. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74: 1746-1751.
63. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast conserving therapy. Cancer. 1996;78:1921-1928.
64. Ohtake T, Abe R, Kimijima I, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conserving surgery: computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer. 1995;76:32-45.
65. Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994;11:181-192.
66. Holland R, Veling SHJ, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990.
67. Faverly D, Holland R, Burgers L. An original stereomicroscopic analysis of the mammary glandular tree. Virchows Arch (A) Pathol Anat Histopathol. 1992;421:115-119.
68. Patchefsky AS, Schwartz GF, Finkelstein SD, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer. 1989;63:731-741.
69. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345:1154-1157.